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Abstract
Antibody fragments are easily isolated from in vitro selection systems, such as phage and yeast display. Lacking the Fc
portion of the antibody, they are usually labeled using small peptide tags recognized by antibodies. In this paper we
present an efficient method to fluorescently label single chain Fvs (scFvs) using the split green fluorescent protein (GFP)
system. A 13 amino acid tag, derived from the last beta strand of GFP (termed GFP11), is fused to the C terminus of the scFv.
This tag has been engineered to be non-perturbing, and we were able to show that it exerted no effect on scFv expression
or functionality when compared to a scFv without the GFP11 tag. Effective functional fluorescent labeling is demonstrated
in a number of different assays, including fluorescence linked immunosorbant assays, flow cytometry and yeast display.
Furthermore, we were able to show that this split GFP system can be used to determine the concentration of scFv in crude
samples, as well an estimate of antibody affinity, without the need for antibody purification. We anticipate this system will
be of widespread interest in antibody engineering and in vitro display systems.
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Introduction
Monoclonal antibodies (mAbs) have long been used for
biological and medical research, as well as in vitro diagnostics.
However, the derivation of mAbs is relatively expensive and time
consuming. Over the past decade, an alternative and effective way
to obtain monoclonal antibodies has been the use of recombinant
antibody display libraries from which antibodies of interest can be
selected and expressed in E. coli [1]. Filamentous phage display [2]
is the most widely distributed display platform, with yeast [3] and
ribosome display [4] also frequently used. The commonest
antibody formats used are single chain Fvs (scFvs) [5] and Fabs.
scFvs are recombinant constructs in which the variable domains of
the heavy and light chains are covalently linked together by a
flexible linker [5], whereas Fabs were originally described by the
digestion of antibody with papain [6], and consist of two protein
fragments, VH-CH1, and VL-CL that can be expressed separately
in the E. coli periplasm where they assemble together [7]. Full-
length antibodies include the Fc region, which, from a reagent
point of view, can be considered to be a large tag recognized by
secondary antibodies or bacterial superantigens, such as protein A
or G. Antibody fragments, in contrast, are usually modified by the
fusion of in-frame tags to the antibody fragment. The commonest
format includes a short peptide tag (e.g. myc [8] or SV5 [9])
recognized by a monoclonal antibody, and a histidine tag that can
be used for purification by immobilized metal affinity chromatog-
raphy [10]. Detection of antibody fragments using peptide tags
generally requires an extra step when compared to the detection of
full-length antibodies, since anti-peptide and subsequent labeled
secondary antibodies are usually required. Given the recombinant
nature of antibody fragments selected from phage display libraries,
it was initially thought it would be relatively trivial to fuse effector
domains directly to antibody fragments. Direct fusion to alkaline
phosphatase has been extremely successful [11–14], with scFv-AP
fusions being relatively well expressed and stable, allowing direct
enzyme linked immunosorbant assays (ELISAs) to be carried out
without the need for additional reagents. In a similar manner,
covalent fusion to green fluorescent protein (GFP) or similar
proteins should allow fluorescent labeling of scFvs. This would also
provide the significant advantage that each scFv would be labeled
with only one fluorophore, potentially allowing scFv quantification
by fluorescence. Although a number of publications [15–17] deal
with the creation of such fluorescent antibody fragments, the yields
have been very disappointing, mainly due to the fact that scFvs
contain disulfide bonds that require oxidizing environments (such
as eukaryotic secretory pathways, or the bacterial periplasm) for
correct folding, while GFP folds in the reducing cytoplasm and not
in the periplasm [18]. This is in contrast to alkaline phosphatase,
which folds in the same oxidizing environments as antibody
fragments, explaining the greater success attained with this fusion.
Recently, a number of reports [19–21] have described split GFP
assays, in which self-complementing fragments of GFP are non-
fluorescent individually, but recreate functional GFP when present
together. One of these systems, in particular [19], is based on a
small 13 amino acid fragment corresponding to the 11
th strand of
GFP (GFP11) that was evolved to have minimal effect on the
function or solubility of the protein to which it is fused. This
peptide can restore fluorescence to an evolved version of the first
10 strands of GFP (GFP1-10) with which it interacts almost
irreversibly. A potential advantage of tagging with the small split
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interference of a full-length GFP attached. Furthermore, the small
split GFP tag is less likely to interfere with normal transport to the
periplasm.
In this study, we described the genetic fusion of the GFP11
peptide to the well-characterized anti-chicken-lysozyme scFv,
D1.3, and its expression and functionality after expression in E.
coli. The utility and detectability of the recombinant antibody was
evaluated in a fluorescence linked immunosorbant assay (FLISA)
[17,22,23], an immunosorbant assay that uses fluorescence rather
than enzymatic activity for detection, in yeast display, and in a
multiplex flow cytometry assay for high-throughput purposes.
Materials and Methods
DNA constructs
The GFP11 Fragment was created by annealing the two
oligonucleotides GFP11-rev (P – GAT CCG CCA CCT GTA
ATC CCA GCA GCA TTT ACG TAC TCA TGA AGG ACC
ATG TGG TCA CGA GT) and GFP11-for (P – ACT CGT GAC
CAC ATG GTC CTT CAT GAG TAC GTA AAT GCT GCT
GGG ATT ACA GGT GGC G). This creates the GFP11
fragment with restriction site ends (ScaI and BamHI) compatible
with the pEP-D1.3 vector [24] (a pET based scFv expression
vector, in which an E coil [25] is in fusion with the scFv)
(Figure 1a). The final construct consists of the D1.3 scFv fused to
GFP11and a His tag at the C terminus (Figure 1b–c), with the E-
coil removed.
In order to generate the yeast display vector, pDNL6-GFP11,
the D1.3-GFP11 fragment was PCR amplified using a modified
GFP11-forward primer that replaces the BamHI restriction site
with NotI. Purified fragments were digested with BssHII and NotI
and cloned into pDNL6, a yeast display vector based on pPNL6
[26] which contains BssHII and NheI as cloning sites in order to
be compatible with our phage display vector, pDAN5 [27]
(Figure 1a).
Antigen preparation
Neutravidin (Pierce Inc.), Lysozyme and Myoglobin, were
purchased (SIGMA Aldrich), while IgE receptor was donated by
Graham Mackay, University of Melbourne. All antigens were
biotinylated using the sulfo NHS biotinylation system (Pierce Inc.)
according to the manufacturer’s instructions. The purified anti-
SV5 antibody was conjugated with alkaline phosphate enzyme
(AP) using the Lightning-LinkTM AP Conjugation Kit (Innova
Biosciences) according to the manufacturer’s instructions.
Figure 1. Split-GFP labeling of scFvs. A. GFP complementation vectors. The scFv-D1.3-GFP11 construct was cloned into a pEP based vector
(left) or a yeast display vector (right). The GFP11 peptide is cloned at the C-terminus of the scFv in order not to interfere with the scFv/antigen-
binding activity. B. Linear representation of the scFv-GFP11 molecule. The sequence of the SV5 tag, followed by the GFP11 sequence and the
six histidine tag (6xHis tag) found at the C terminus of the scFv is shown. C. Split GFP fragment complementation. The scFv is fused to the small
GFP fragment (strand 11, residues 215-230). The complementary GFP fragment (1-10, residues 1-214) is expressed separately. Neither fragment alone
is fluorescent. When mixed, the small and large GFP fragments spontaneously associate, resulting in reconstitution of the fluorophore and
fluorescence. D. Split GFP fragment complementation in scFv yeast display. The scFv in fusion with the GFP11 strand is displayed on yeast
cells. It is still able to bind the specific antigen and fluorescence is restored when yeast cells are incubated with the GFP1-10 fragment.
doi:10.1371/journal.pone.0025727.g001
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GFP1-10
pEP-D1.3-GFP11 and pEP-D1.3-Ecoil DNA were transformed
into BL21 (DE3) (Novagen). Bacteria were grown in 50 ml of auto-
induction media [28] at 25uC overnight to produce the
recombinant protein.
Bacteria were harvested and resuspended in 10 ml PBS. Lysis
was performed by means of a pressure press (EmulsiFlex–C5,
Avestin Inc.). The bacterial debris was pelleted by centrifugation,
and the protein purified from the supernatant using the C-terminal
His-tag and Ni-NTA agarose resin (Qiagen Inc.) according to the
manufacturer’s instructions. Purified protein was dialyzed against
PBS and stored at 220uC.
Crude protein extract or bacterial culture supernatant was used.
Afterexpression in1 mlof selectiveauto-inductionmedia, cellswere
harvested, the supernatant was recovered, and the pellet resus-
pendedin1/10 volume ofPopculture (Novagen)solution.Lysis was
performed for 25 minutes at room temperature (RT), with shaking,
and the suspension used after centrifugation without further protein
purification. GFP 1-10 was prepared as previously described
[19,29,30]; 75 mg of inclusion body GFP1-10 was unfolded in 1
ml 9 M urea, and refolded in 20 ml TNG buffer (100 mM Tris HCl
pH 7.5, 150 mM NaCl, 10% v/v glycerol) prior to use. Quanti-
fication was carried out by comparing the intensity of purified scFv-
D1.3-GFP11 to known concentrations of BSA standards on poly-
acrylamide gel stained with gel code (Pierce Inc.).
Complementation assay
A 96-well microplate was first blocked with a solution of 0.5%
bovine serum albumin (BSA) in PBS for 30 minutes. Different
concentrations of purified scFv-D1.3-GFP11 were prepared (75,
150, 300 pmol) in a final volume of 100 ml. A large molar excess
(800 pmol) of GFP 1-10 in 180 ml was added and complementa-
tion carried out. Crude Pop-culture E.coli lysate was also tested
using two fold serial dilutions in a final volume of 50 ml, incubated
with a similar large molar excess of GFP1-10.
Fluorescence (lexc=488 nm/lem =530 nm) was monitored
using a Tecan Infinite M200 reader measuring at 3 minutes
intervals for 20 hours for the purified protein and 10 hours for the
crude extracts at room temperature (RT).
Calibration curve
To correlate the fluorescent signal with the D1.3-GFP11 protein
quantity present in the crude bacteria extract, two calibration
curves were generated by measuring the fluorescence after split-
GFP complementation of a control antigen, sulfite-reductase (SR-
GFP11), which we have used extensively [29] and of purified scFv-
D1.3-GFP11, both of known concentration (range 1.5–160 pmol)
and molecular weight. Forty ml of purified protein solutions or total
cell extract were mixed with 190 ml of 800 pmol GFP 1-10 protein
solution. The samples were incubated over night (ON) at 4uC.
Fluorescence was measured using the Beckman Coulter DTX-880
Multimode Detector. The quantity of scFv-D1.3-GFP11 in the
crude bacteria extract was calculated using the equations in
Canbantou et al [31].
Enzyme linked immunosorbant assay (ELISA)
100 ml of neutravidin solution (10 mg/ml concentration) were
added to each well of an ELISA plate (Nunc 442404) and
incubated at 37uC for 1 hour in order to coat the plate. The wells
were washed twice with PBSLT (PBS, Tween 20 0.05%), then
blocked with 200 ml of 1% BSA in PBS for 1 hour at RT. The
blocking solution was washed away with PBSLT. 100 mlo f
biotinylated antigen (10 mg/ml) were added to each well and
incubated for 30 minutes at RT. After extended washing with
PBSLT, 100 ml of different concentrations of the scFv-D1.3-
GFP11 or D1.3-Ecoil purified protein (range 0.6 – 300 nM) were
added and incubated for 1 hour at room temperature. Unbound
proteins were removed by washing three times with PBST (PBS,
Tween 20 0.5%) and three times with PBSLT. 100 ml of anti-SV5
AP (1mg/ml) solution was added and incubated for 1 hour at RT.
Washing steps were repeated (3xPBST, 3xPBSLT), and alkaline
phosphatase activity detected using PNPP solution (Sigma) with
absorbance read at 405 nm.
Equilibrium binding titration curve for the complemented
D1.3-GFP11 to determine the affinity constant Kd of scFv-D1.3-
GFP11 was obtained by nonlinear regression using PRISM
software (version 5.0 Graph Pad).
Fluorescence linked immunosorbant assay (FLISA)
Neutravidin coating and antigen binding were performed
following the ELISA protocol, except that black (Nunc 43711)
ELISA plates were used as previously described [23]. After antigen
coating, 50 ml of different concentrations of the scFv-D1.3-GFP11
purified protein (ranging from 0.6 to 300 nM),, were added and
incubated for 1 hour at RT. Unbound proteins were removed by
washing three times with PBST and three times PBSLT. 90 mlo f
800 pmol GFP1-10 were added to each well and fluorescence was
read after 4 hours at RT.
Equilibrium binding titration curve to determine the affinity
constant Kd of scFv-D1.3-GFP11 was obtained by using nonlinear
regression running PRISM software (version 5.0 Graph Pad).
Yeast display
The scFv-D1.3-GFP11 construct was cloned into the yeast
display vector pDNL6, to create pDNL6-GFP11, and transformed
into S. cerevisiae EBY100 according to the Yeast transformation kit
manual (Sigma). A single clone was then grown in SD-CAA
selective media at 30uC. Cells were diluted to 0.5 OD600 in
induction media SG/R + CAA and incubated at 20uC with
Figure 2. Comparison of antigen binding activity assessed by
ELISA. The antigen binding activity was analyzed by ELISA using
different concentrations of scFv-D1.3 and scFv-D1.3-GFP11 scFvs
(ranging from 0.6 to 300 nM). The scFv-D1.3-GFP11 construct showed
good binding activity for lysozyme (lys) even after incubation with the
GFP1-10 complementing protein, indicating the absence of steric
hindrance between the restored GFP protein and the anti-SV5 antibody
used for detection. Myoglobin (myo) was used as negative control.
doi:10.1371/journal.pone.0025727.g002
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6 yeast induced cells were washed
with 1 ml of washing buffer (PBS, BSA 0.5%, EDTA 20mM) and
resuspended in 100 ml containing: i) 1 ml of anti-SV5 mAb (1 mg/
ml) plus 100 nM biotinylated antigen together; ii) anti-SV5 alone;
or iii) biotinylated antigen alone. After 30 minutes of incubation at
RT followed by 5 minutes on ice, cells were spun down and
washed twice with 500 ml of ice-cold washing buffer.
Cells were resuspended in 100 ml of a 1/200 dilution of
secondary reagents: streptavidin-Alexa633 for antigen detection
and anti-mouse-PE conjugated for anti SV5-scFv detection. The
cells were incubated for 30 minutes in ice, harvested and washed
twice with cold buffer. Cells were then resuspended in 1 ml of PBS
or GFP1-10 solution (3.75 mg/ml, 4 mM).
Florescence data were collected using BD FACSAria flow
Cytometer and analyzed using DIVA software. The yeast
population was gated and the mean fluorescent values for PE
(corresponding to scFv expression), APC (corresponding to antigen
binding) and FITC (corresponding to complementation of scFv-
D1.3-GFP11 with GFP10) were recorded using appropriate
excitation lasers and emission filters.
Multiplexed Flow Cytometry
Three different color-coded, carboxylated microsphere sets
were used (Luminex, xMAP 135, 129, 159). Each individual set
was coupled with Neutravidin, coupling was quantified [24], and
biotinylated antigens were respectively bound: lysozyme to beads
135, myoglobin to beads 129 and IgE receptor to beads 159.
16 ml (1.6610
5 microspheres) of each bead set were incubated
with 100 ml of different concentrations of purified protein (ranging
from 0.38 to 380 pmol) or with POP culture extract. The solutions
were then incubated with a molar excess of GFP1-10 for two hours
at RT, and the mean fluorescence data of each bead set was
collected using the high-throughput analysis feature of a Becton
Dickinson LSRII Flow Cytometer and analyzed using the DIVA
software package. The bead multiplex was separated into gates
using the setting previously described [24] and the mean
fluorescent value of each gate was recorded following excitation
using 488 nm laser through FITC detectors. Equilibrium binding
titration curves to determine the affinity constant Kd of scFv-D1.3-
GFP11 was obtained by nonlinear regression using PRISM
software (version 5.0 Graph Pad).
Figure 3. Progress curves analysis of the complemented fluorescence. A. Progress curves of complemented fluorescence using
purified protein. The increasing fluorescence over time was determined (a.u arbitrary units) for the complementation of scFv-D1.3-GFP11 samples
at different concentrations (300, 150, 75 pmol) incubated with an excess of GFP1-10 (800 pmol). Fluorescence (lexc=488 nm/lem=530 nm) was
monitored at 3 minutes intervals for 20 h at RT. B. Progress curves of complemented fluorescence using serial dilutions of crude bacteria
extract. A similar trend of increasing fluorescence was measured (a.u arbitrary units) directly using serial dilution of crude bacterial culture extract,
albeit at lower fluorescent values. Fluorescence (lexc=488 nm/lem=530 nm) was monitored at 3 minutes intervals for 10 hours at RT.
doi:10.1371/journal.pone.0025727.g003
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The small 13-amino-acid 11
th strand of GFP (GFP11) was
generated by PCR, annealing two phosphorylated oligonucleotides
with appropriate restriction sites and cloning at the C-terminus of
the D1.3 scFv gene in the pEP vector (Fig. 1). The His-tag at the
C-terminus of GFP11 was used for purification by immobilized
metal chromatography. The yield of scFv-D1.3-GFP11 was up to
5 mg per liter of bacterial culture.
Binding activity comparison
To determine whether fusion to the GFP11 peptide interferes
with the expression and binding activity of the scFv, the scFv-
D1.3-GFP11 molecule was compared to an essentially identical
D1.3 scFv in fusion with the E-coil peptide [25], and lacking the
GFP11 tag.
Equal quantities of D1.3-E-coil and scFv-D1.3-GFP11 were used
in an ELISA assay. The antibody antigen interaction was detected
using SV5 antibodies and the scFv-D1.3-GFP11 was used with and
without GFP1-10 incubation. The results were very similar for both
constructs, at differentconcentrations,whether GFP1-10 was added
or not, indicating that the GFP11 tag does not sterically hinder
binding to the SV5 tag, even when the GFP molecule is fully
complemented at the C-terminus of the scFv (Figure 2).
Complementation assay
In order to determine how effectively split GFP could be used to
label a scFv molecule, we tested the complementation between serial
dilutions of purified scFv-D1.3-GFP11 protein (75, 150, 300 pmol)
and a molar excess of GFP1-10 (800 pmol). We measured the
progression of fluorescence, indicating complementation, in a
microtiter plate (Figure 3a). The fluorescent signal could be easily
detected when illuminated at 488 nm within an hour after the
addition of the complementary fragment GFP1-10 at room
temperature with the fluorescence levels directly related to the
different concentrations of scFv-D1.3-GFP11. In the absence of
GFP1-10, there was no fluorescence. As protein purification is a time
consuming process, we also carried out the assay using serial dilutions
of a crude bacterial lysate. The curves obtained showed a significant
increase in fluorescence after incubation with the GFP1-10 fragment,
directly related to the scFv-D1.3-GFP11 dilution (Figure 3b).
Quantification of scFv-D1.3-GFP11 using calibration
curves
In previous papers, GFP complementation using the GFP11 tag
has been used to quantify proteins in E. coli [29] and eukaryotic
cell extracts [32]. We assessed the ability to use the GFP11 tag to
quantify scFvs in crude cell extracts using two standard curves
prepared with complemented dilutions of sulfite-reductase GFP11
and purified scFv-D1.3-GFP11. Sulfite-reductase is the protein
standard that we have previously used to calibrate GFP11 tagged
proteins [30,31,33]. As shown in figure 4, there is a direct linear
relationship between fluorescence and the concentration of SR-
GFP11 and scFv-D1.3-GFP11, resulting in two almost superim-
posable calibration curves. By measuring the fluorescence of a
complemented sample of crude scFv-D1.3-GFP11 obtained from
bacterial expression in deep well microtiter plates, and using the
equation presented in Cabantous et al. [31], we were able to
calculate the expression level of complemented scFv-D1.3-GFP11
under these conditions to be 5.6 mg/ml. This is approximately ten
fold less than the amount of protein we routinely obtain from
expression in large flasks, where aeration is signficantly better, and
purification is probably more efficient.
Fluorescence linked immunosorbant assay (FLISA)
Having shown that GFP11 was functional when fused to the C
terminus of an scFv, we tested the antigen binding properties of
the fluorescent scFv using a fluorescent linked immunosorbant
assay [23], which exploited the fluorescence of the complemented
GFP11. We have previously shown that FLISA is an effective and
more rapid alternative to the use of ELISA to screen scFvs, when
those scFvs are made fluorescent [23]. In particular, it is a single
step assay that does not require additional incubations, beyond the
addition of the fluorescently labeled antibody. Figure 5 shows that
the assay has a very high signal to noise ratio when scFvs are
fluorescently labeled using the split GFP system. An approxima-
Figure 4. GFP1-10 standard curves to evaluate protein
concentration. A GFP11 standard plot was constructed using
increasing amounts of sulfite reductase GFP11 (SR-GFP11) and scFv-
D1.3-GFP11 (ranging from 1.5 to 160 pmol) in a molar excess of GFP1-
10. The quantity of GFP11 tagged scFv in the cell extract was calculated
according to the equations presented in Canbantou et al. [31]. In all
cases fluorescence (a.u. arbitrary units) was measured after overnight
incubation at 4uC.
doi:10.1371/journal.pone.0025727.g004
Figure 5. FLISA results at different complemented scFv-GFP11
concentrations. scFv-D1.3-GFP11 was used in a FLISA assay with
binding between the scFv and its specific antigen assessed by
complemented fluorescence. No signal was detected for the negative
control myoglobin.
doi:10.1371/journal.pone.0025727.g005
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regression using the PRISM software package (version 5.0 Graph
Pad) as 41.4 nM. This value is similar to that obtained when
affinity was estimated by ELISA: Kd 25.2 nM. This falls within
the range (3-500 nM) of most estimates of D1.3 affinity calculated
using a number of different methods [34,37–41], indicating the
further utility of GFP complementation in affinity determination.
Although the absence of fluorescence in the non-complemented
GFP1-10, ensures that only the scFv is fluorescent, this does not
avoid a small degree of non-specific binding of the complemented
scFv to the negative control antigen (myoglobin), and will depend
upon the specific binding properties of each individual scFv.
Yeast display
Yeast display [3] is a technique in which antibodies are
displayed on the surface of yeast particles and selected on the basis
of their ability to bind to fluorescently labeled antigens. Clones
showing increased binding can then be sorted from those showing
less binding. In order to ensure that selected clones have higher
affinity and not merely increased display levels, binding is usually
normalized using an antibody recognizing a peptide tag at the C
terminus of the antibody. Given the results we obtained above, it
became clear that we may be able to use GFP complementation to
carry out normalization of display rather than using anti-tag
antibodies. We created yeast display constructs in which scFv-D1.3
was displayed on the surface, containing both the GFP11 peptide
as well as the peptide epitope recognized by SV5 (Figure 1d).
Biotinylated lysozyme was detected using Alexa 633 labeled
streptavidin, and display levels were assessed using either GFP1-10
or phycoerythrin labeled SV5. The results in figure 6 show that
labeling by GFP complementation was essentially as effective in
normalizing display levels as the use of PE labeled SV5. The only
major difference between the two labeling methods was that
labeling was more intense with Phycoerythrin labeled SV5,
reflecting the fact that each Phycoerythrin contains 34 fluoro-
chromes while each GFP contains a single fluor [35,36]. This
demonstrates the potential utility of using split GFP to label
antibodies in this application as well.
Multiplex
In a recent paper we demonstrated the advantages of multiplex
flow cytometry in the screening of scFvs following selection [24].
In that paper, scFvs were labeled using a fluorescent K coil that
bound to an E coil appended to the C terminus of the scFv.
Although we were able to obtain high signal to noise using this
labeling system, one problem is that the fluorescently labeled K
coil is fluorescent even when not bound to scFv, and under some
circumstances demonstrated some binding activity of its own. One
Figure 6. Yeast display of scFv-D1.3-GFP11. The scFv-D1.3-GFP11 containing both the GFP11 peptide as well as the peptide epitope recognized
by SV5 was displayed on the surface of yeast cells. Biotinylated lysozyme was detected using Alexa 633 labeled streptavidin, and display levels were
assessed using either GFP1-10 or phycoerythrin labeled SV5. Labeling by GFP complementation was essentially as effective in normalizing display
levels as the use of PE labeled SV5.
doi:10.1371/journal.pone.0025727.g006
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only the complemented GFP1-10 is fluorescent. Since the only
source of GFP11 is that fused to the scFv, this should improve
signal to noise, by eliminating extraneous fluorescence.
Functional analysis of the scFv-D1.3-GFP11 construct was first
performed using purified protein, to correlate the fluorescent signal
with a precise amount of scFv. In this first experiment two sets of
beads were used, one coated with the specific antigen lysozyme
and one with myoglobin as a negative control. The fluorescence
values obtained showed excellent correlation between the
concentration of the fluorescently labeled scFv and the signal
(Figure 7a), even down to relatively low concentrations (5 nM).
Furthermore, titration of the GFP complemented scFv allowed us
to calculate the approximate affinity by nonlinear regression (using
PRISM), as 2964 nM, similar to the values obtained above by
ELISA and FLISA.
In general, the most time-consuming aspect of affinity
determination is purification of the scFv and the determination
of concentration. Given that we were able to obtain the
concentration of scFv-D1.3-GFP11 in the bacterial lysate using
the standard curve in figure 4 (5.6 mg/ml) we also attempted to
determine the affinity of the D1.3 scFv using crude samples, rather
than the purified samples described above. Complementation was
carried out with a molar excess of GFP1-10 added to serial
dilutions of POP culture (EMD) extract. The results clearly
demonstrate the ability to detect antibody bound to specific
antigen (lysozyme) and not to the negative controls (myoglobin
and IgER) (Figure 7b), without the need for purification. This
allowed us to approximate the affinity of D1.3 scFv in the crude
extract to 3867 nM, similar to the value of 29 nM previously
obtained using purified scFv (Figure 7a). This indicates the value of
the split GFP system to calculate approximate scFv affinities that
can be used in screening, particularly in high throughput multiplex
processes in which protein purification can be avoided.
Discussion
Fluorescently labeled antibodies can be extremely useful
research and diagnostic tools. Full-length antibodies have been
chemically linked to different fluorophores, including FITC,
TRITC CY-3 and CY-5. This sometimes leads to reduced
binding to target antigen, especially when conjugation occurs
within the antigen binding site [42]. It is also difficult to control the
number of labels incorporated, with considerable variability from
antibody to antibody. Direct conjugation of scFv molecules to
fluorescent dyes (e.g. CY-5) has also been carried out [43],
although this requires prior scFv purification. Many reports
describing direct fusion of GFP to scFvs have been published
[15,16,18,44–46]. However conventional scFv are prone to
aggregation and the fusion between scFv and GFP augments
these scFv aggregation tendencies. Furthermore, careful reading of
these reports reveals that the yields for scFv-GFP fusions are
extremely low, due to the incompatible folding requirements of the
two moieties: antibody fragments prefer oxidizing environments,
while fluorescent proteins prefer reducing environments. One
exception to this general trend has been the fusion of GFP to scFvs
that can fold and are functional in the cytoplasm [46]. More
recently recognition molecules based on GFP with antibody-like
binding proprieties have been described [47], representing an
interesting new approach to the creation of fluorescent affinity
reagents.
The split GFP system is able to overcome problems of
expression and folding while providing fluorescent labeling
characteristics to the scFv. As the GFP11 tag was evolved to be
minimally intrusive [19], its fusion to the C terminus of proteins,
including scFvs, has little effect on expression, solubility or folding.
This property should expand the choices of cellular compartments
Figure 7. Affinity determination. A. Affinity determination by
multiplexed assay using purified protein. After 2 hours of
complementation with the GFP1-10 fragment, the scFv-D1.3-GFP11
shows specific binding to its antigen, chicken lysozyme, and no binding
activity to the negative control, myoglobin. Fluorescence values are
plotted versus the different concentrations of purified scFv-D1.3-GFP11
giving a Kd value of 2964 nM. Data are fit with a nonlinear least
squares regression and are visualized with the concentration values on
a log scale. B. Affinity determination by multiplexed assay using
serial dilution of bacterial lysate (POP culture extract) obtained
from induced cells. Unpurified scFv-D1.3-GFP11 obtained from
induced bacteria shows specific binding to lysozyme, but not to
myoglobin or IgE receptor. Fluorescence values are plotted versus the
different concentrations of scFv-D1.3-GFP11 present in crude bacteria
extract calculated by reference to the GFP complementation standard
(figure 4), resulting in a Kd value of 3867 nM. Data are fit with a
nonlinear least squares regression and are plotted with the concentra-
tion values on a log scale.
doi:10.1371/journal.pone.0025727.g007
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Furthermore, as the GFP11 tag is located at the opposite end of
the binding interface, antigen-binding activity is preserved even
when interacting with the complementary GFP1-10 fragment, as
shown in figure 2.
A first series of experiments was carried out to investigate the
possibility of fusing the GFP11 peptide to the C terminus of scFvs.
We constructed a vector based on our pEP series [24]. This
contained the SV5, GFP11 and His6 tags fused to the C terminus
of the scFv, with restriction sites (BssHII and NheI) compatible with
our phage display vector, pDan5 [27], allowing rapid transfer
following antibody selection by phage display (figure 1). The levels
of scFv-GFP11 recovered after expression is comparable to the
normal recovery of the same scFv-D1.3 without the GFP11 tag.
The complementation between scFv-D1.3-GFP11 and GFP1-10
completely restores GFP fluorescence, conferring a highly stable
fluorescence to the scFv, without interfering with the antigen
binding activity of the single chain, as shown by the ELISA
(figure 2) and FLISA experiments (figure 5). Comparing FLISA
(figure 5) and ELISA (figure 2) carried out similarly, shows that
ELISA is approximately twice as sensitive, able to detect down to
,2.5 nM, while FLISA has a limit of detection of ,5 nM). Once
complementation has been carried out, detection using FLISA and
GFP complementation does not require additional secondary
reagents. Furthermore, as fluorescence is quantitative, it does not
require protein purification, and providing the GFP1-10 is in
molar excess, can be used to directly determine the amount of a
GFP11 tagged protein in a crude mixture, as shown in figures 4.
We were also able to show that GFP complementation can be used
effectively in yeast display to label displayed scFvs, as an
alternative to secondary antibodies. Furthermore, scFvs labeled
with complemented GFP can be used in FLISAs (figure 5) and
multiplexed flow cytometry (figure 6) to determine the approxi-
mate affinity of scFv of either purified (figure 7a) or crude
(figure 7b) scFv preparations with similar levels of accuracy. This is
likely to be of enormous utility in the high throughput selection
and characterization of antibodies against large numbers of
targets, where the ability to determine affinity rank without
protein purification will increase the level of characterization that
can be carried out. The use of GFP complementation to label
scFvs has three advantages over the use of other methods: first
each scFv is labeled with a single GFP molecule, second, the
interaction between GFP11 and GFP1-10 is essentially irreversible
under physiological conditions [19], and finally background due to
fluorescent secondary reagents is eliminated as fluorescence is only
generated upon complementation, although background due to
adventitious by the scFv cannot be avoided.
Together these results show the great potential utility of GFP
complementation in the use of scFvs in high throughput
applications, including quantification, FLISA, multiplexed flow
cytometry, affinity determination and yeast display.
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